Bi-specific chimeric antigen receptor
Grant
US12590145B2
Kind: B2
Mar 31, 2026
Assignee
The Regents of the University of California
Inventors
Yvonne Yu-Hsuan Chen, Zenan Li Chang
Abstract
Aspects of the disclosure relate to polypeptides comprising a signal peptide, an antigen-binding domain that specifically binds TGF-β, a peptide spacer, a transmembrane domain, and an endodomain. When expressed in a cell, the polypeptides are capable of not only neutralizing the TGF-β but also specifically triggering T-cell activation in the presence of TGF-β. T-cell activation spurs the immune cell to produce immunostimulatory cytokines and proliferate, thus turning TGF-β from an immunosuppressive signal to an activating stimulus.
CPC Classifications
C07K 16/22
C07K 14/7051
C07K 2317/33
A61K 39/0008
A61K 2039/5158
Filing Date
2021-05-18
Application No.
17323568
Claims
10